×
Back to Agenda
Asian Town Hall
Session Chair(s)
Nobumasa Nakashima
Professor, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
“Regulatory convergence” has been advancing in Asia and expectation to this region as a field of drug development is also increasing. This session shares latest efforts for “regulatory convergence” in Asia and discuss future direction.
Learning Objective : Describe activities to promote convergence in Asian country; Discuss activities based on convergence in Asian country; Discuss findings from FDA’s perspective.
Speaker(s)
Si Yuan Zhou
Director of CDE, Head of ICH China Office, National Medical Products Adminsitration (NMPA), China
NMPA Perspective
Sia Chong Hock, MSC
Senior Consultant, Audit and Licensing, Director Quality Assurance, Health Sciences Authority (HSA), Singapore
ASEAN Convergence in Pharmaceutical Inspections
Michelle Limoli, PHARMD, RPH
Associate Director, International Programs, FDA, United States
FDA Perspective
Have an account?